Thalidomide administration for the treatment of resistant plasma cell leukemia
| dc.contributor.author | Tsiara, S. | en |
| dc.contributor.author | Chaidos, A. | en |
| dc.contributor.author | Kapsali, H. | en |
| dc.contributor.author | Tzouvara, E. | en |
| dc.contributor.author | Bourantas, K. L. | en |
| dc.date.accessioned | 2015-11-24T19:42:40Z | |
| dc.date.available | 2015-11-24T19:42:40Z | |
| dc.identifier.issn | 0001-5792 | - |
| dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/24676 | |
| dc.rights | Default Licence | - |
| dc.subject | Adjuvants, Immunologic/adverse effects/therapeutic use | en |
| dc.subject | Aged | en |
| dc.subject | Angiogenesis Inhibitors/adverse effects/*therapeutic use | en |
| dc.subject | Drug Tolerance | en |
| dc.subject | Female | en |
| dc.subject | Humans | en |
| dc.subject | Leukemia, Plasma Cell/*drug therapy/etiology | en |
| dc.subject | Middle Aged | en |
| dc.subject | Multiple Myeloma/complications/therapy | en |
| dc.subject | Thalidomide/adverse effects/*therapeutic use | en |
| dc.title | Thalidomide administration for the treatment of resistant plasma cell leukemia | en |
| heal.access | campus | - |
| heal.fullTextAvailability | TRUE | - |
| heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/12747371 | - |
| heal.identifier.secondary | http://content.karger.com/ProdukteDB/produkte.asp?doi=10.1159/000069284 | - |
| heal.journalName | Acta Haematol | en |
| heal.journalType | peer-reviewed | - |
| heal.language | en | - |
| heal.publicationDate | 2003 | - |
| heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
| heal.type | journalArticle | - |
| heal.type.el | Άρθρο Περιοδικού | el |
| heal.type.en | Journal article | en |
Αρχεία
Φάκελος/Πακέτο αδειών
1 - 1 of 1
Φόρτωση...
- Ονομα:
- license.txt
- Μέγεθος:
- 1.74 KB
- Μορφότυπο:
- Item-specific license agreed upon to submission
- Περιγραφή: